U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898072) titled 'Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism' on Oct. 21.
Brief Summary: The goal of this Phase 3 clinical trial is to evaluate the safety, efficacy, and usability of a weekly subcutaneous testosterone cypionate auto-injector in adult males with hypogonadism. The main questions it aims to answer are:
* Does weekly testosterone cypionate administered using an auto-injector maintain testosterone levels within the normal range in adult males with hypogonadism?
* What side effects and safety outcomes occur during treatment with testosterone cypionate auto-injector?
* Is the auto-injector...